Evidence map›Paper›PMID 30061707›Full record

ArticleThe ISME journal2018

Adaptive mechanisms that provide competitive advantages to marine bacteroidetes during microalgal blooms.

Frank Unfried, Stefan Becker, Craig S Robb, Jan-Hendrik Hehemann, Stephanie Markert, Stefan E Heiden, Tjorven Hinzke, Dörte Becher, Greta Reintjes, Karen Krüger and 10 more

Abstract read
In one paragraph

Article in The ISME journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed.

  1. Article
  2. Characterization of a GH17 laminarinase,Applied and environmental microbiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Draft genome sequence ofMicrobiology resource announcements · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The catabolic specialization of the marine bacteriumApplied and environmental microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Frank UnfriedPharmaceutical Biotechnology, University Greifswald, Greifswald, Germany.ORCID http://orcid.org/0000-0002-9304-4947
Stefan BeckerMax Planck Institute for Marine Microbiology, Bremen, Germany.ORCID http://orcid.org/0000-0002-9619-3542
Craig S RobbMax Planck Institute for Marine Microbiology, Bremen, Germany.
Jan-Hendrik HehemannMax Planck Institute for Marine Microbiology, Bremen, Germany.
Stephanie MarkertPharmaceutical Biotechnology, University Greifswald, Greifswald, Germany.
Stefan E HeidenPharmaceutical Biotechnology, University Greifswald, Greifswald, Germany.
Tjorven HinzkePharmaceutical Biotechnology, University Greifswald, Greifswald, Germany.
Dörte BecherInstitute of Marine Biotechnology, Greifswald, Germany.
Greta ReintjesMax Planck Institute for Marine Microbiology, Bremen, Germany.ORCID http://orcid.org/0000-0001-7085-4683
Karen KrügerMax Planck Institute for Marine Microbiology, Bremen, Germany.
Burak AvcıMax Planck Institute for Marine Microbiology, Bremen, Germany.ORCID http://orcid.org/0000-0002-2358-7671
Lennart KappelmannMax Planck Institute for Marine Microbiology, Bremen, Germany.
Richard L HahnkeMax Planck Institute for Marine Microbiology, Bremen, Germany.ORCID http://orcid.org/0000-0002-1105-6363
Tanja FischerMax Planck Institute for Marine Microbiology, Bremen, Germany.
Jens HarderMax Planck Institute for Marine Microbiology, Bremen, Germany.
Hanno TeelingMax Planck Institute for Marine Microbiology, Bremen, Germany.
Bernhard FuchsMax Planck Institute for Marine Microbiology, Bremen, Germany.ORCID http://orcid.org/0000-0001-9828-1290
Tristan BarbeyronNational Center of Scientific Research/Pierre and Marie Curie University, Paris, France.
Rudolf I AmannMax Planck Institute for Marine Microbiology, Bremen, Germany.
Thomas SchwederPharmaceutical Biotechnology, University Greifswald, Greifswald, Germany. schweder@uni-greifswald.de.ORCID http://orcid.org/0000-0002-7213-3596

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polysaccharide degradation by heterotrophic microbes is a key process within Earth's carbon cycle. Here, we use environmental proteomics and metagenomics in combination with cultivation experiments and biochemical characterizations to investigate the molecular details of in situ polysaccharide degradation mechanisms during microalgal blooms. For this, we use laminarin as a model polysaccharide. Laminarin is a ubiquitous marine storage polymer of marine microalgae and is particularly abundant during phytoplankton blooms. In this study, we show that highly specialized bacterial strains of the Bacteroidetes phylum repeatedly reached high abundances during North Sea algal blooms and dominated laminarin turnover. These genomically streamlined bacteria of the genus Formosa have an expanded set of laminarin hydrolases and transporters that belonged to the most abundant proteins in the environmental samples. In vitro experiments with cultured isolates allowed us to determine the functions of in situ expressed key enzymes and to confirm their role in laminarin utilization. It is shown that laminarin consumption of Formosa spp. is paralleled by enhanced uptake of diatom-derived peptides. This study reveals that genome reduction, enzyme fusions, transporters, and enzyme expansion as well as a tight coupling of carbon and nitrogen metabolism provide the tools, which make Formosa spp. so competitive during microalgal blooms.

Indexed as

EutrophicationAdaptation, PhysiologicalBacterial ProteinsBacteroidetesCarbon CycleFlavobacteriaceaeGlucansHydrolasesMetagenomicsMicroalgaeNorth SeaPhytoplanktonPolysaccharidesBacterial ProteinsGlucansHydrolaseslaminaranPolysaccharides

Identifiers

PMID30061707
PMCPMC6246565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.